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Promotion of a More Differentiated, Less Malignant
and Indolent Phenotype
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The calcium sensing receptor (CaSR) is a robust promoter of differentiation in colonic epithelial cells and functions as a
tumor suppressor. Cancer cells that do not express CaSR (termed CaSR null) are highly malignant while acquisition of CaSR
expression in these cells circumvents themalignant phenotype.We hypothesize that chemopreventive agentsmediate their
action through the induction of CaSR. Here, we compare the effectiveness of Ca2þ, vitamin D, and Aquamin (a marine
algae product containing Ca2þ, magnesium and detectable levels of 72 additional minerals) on the induction of CaSR in the
CBS andHCT116 human colon carcinoma cell lines and the correspondingCaSR null cells isolated from these lines. All three
agonists induced CaSRmRNA and protein expression and inhibited cellular proliferation in the parental and CaSR null cells.
Aquamin was found to be most potent in this regard. Induction of CaSR expression by these agonists resulted in
demethylation of the CaSR gene promoter with a concurrent increase in CaSR promoter reporter activity. However,
demethylation per se did not induce CaSR transcription. Induction of CaSR expression resulted in a down-regulated
expression of tumor inducers and up-regulated expression of tumor suppressors. Again, Aquamin was found to be most
potent in these biologic effects. This study provides a rationale for the use of a multi-mineral approach in the
chemoprevention of colon cancer and suggests that induction of CaSR may be a measure of the effectiveness of
chemopreventive agents. © 2013 Wiley Periodicals, Inc.
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INTRODUCTION
The extracellular calcium sensing receptor (CaSR) is
a 7-transmembrane -spanning G-protein coupled
receptor originally identified in the parathyroid
gland [1,2]. In the parathyroid, CaSR function
unequivocally as a calcium sensor, where it senses
minute changes in extracellular calcium concentra-
tion and regulate the secretion of parathyroid
hormone accordingly to maintain Ca2þ homeosta-
sis [1–3]. CaSR is expressed in a variety of tissues and
cell type not involved in Ca2þ regulation [4–7]. CaSR
is expressed in the colonic epithelium and recent
studies suggest that CaSR is a robust promoter of
differentiation in the colon and functions as a tumor
suppressor [8–15].Wehave initially shown that loss of
CaSR expression correlates with the phenotype of
undifferentiated and invasive human colon tumors
and activation of b-catenin signaling in these
tumors [8,9,11]. Other groups have reported on the
lack of CaSR expression (both mRNA and protein),
methylation of CpG islands in the CaSR gene
promoter and activation of b-catenin in advanced
colon cancer [16]. Intestinal specific CaSR knock out
inmice results in hyperproliferation, expansion of the
proliferation zones, changes in crypt structures and
enhanced b-catenin nuclear localization; establishing
a definitive negative cross talk between CaSR and b-
catenin signaling in the colonic epithelium [13]. Loss
of CaSR is regarded as a key event in the pathogenesis
of colon cancer [12].
Loss of CaSR expression may allow cellular escape
from Ca2þ mediated growth control. In the colonic
crypts, stem cells in the basal zone of a crypt do not
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mesenchymal transition; hESC, human embryonic stem cell culture
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express CaSR [9]. Colonic crypt cells gain CaSR
expression as they migrate and differentiate upwards
in the direction of the lumen [9,12]. Exactly what
triggers CaSR expression as the colonic crypt cells
migrate and differentiate in the crypt is not known.
Human colon carcinoma cell lines express CaSR, albeit
the expression profile is heterogeneous with cells
showing different levels of CaSR expression [14,17].
Although extracellular Ca2þ can up-regulate CaSR
expression and induces a more differentiated and
benign phenotype in these cell lines [8,9,11,17], a
small percentage of cells in a cell line (similar to
colonic crypt stem cells) do not express CaSR (termed
CaSR null). We have recently isolated and character-
ized CaSR null cells from the human colon carcinoma
CBS andHCT116 cell lines and demonstrated that the
null status of these cells can be maintained in
supplemental human embryonic stem cell (hESC)
culture medium. These CaSR null cells possess a
myriad of molecular features that underlie a highly
malignant phenotype [14]. Thus, CaSR null cells
maintained in hESC medium offer an in vitro model
in determining the triggers and the underlying
mechanisms of CaSR induction that may reflect on
mechanisms applicable to cells in the colonic crypt
in vivo.
Dietary calcium and vitamin D possess chemo-
preventive properties against colon cancer and vita-
min D also acts to promote calcium absorption in the
gut [8,9,11,18]. Both Ca2þ and vitamin D have been
reported to act through CaSR tomediate their growth-
inhibitory and differentiation-promoting effects
[8,9,11,17,19]. Activation of CaSR by Ca2þ or other
CaSR agonists suppresses the malignant phenotype of
human colon carcinoma cells through effects on a
variety of cellular and molecular events. Activation of
CaSR inhibits cell proliferation; invasion and anchor-
age-independent growth [8,9,11,14,17,19]; promotes
the expression of the tumor suppressor E-cad-
herin [8,10,11,20]; up-regulates the expression of the
growth-inhibitory anddifferentiation relatedp21/Waf1
cell cycle check point protein; up-regulates the
expression of g-catenin and p27/Kip1; suppresses the
malignancy-associated b-catenin/Wnt, c-myc and
cyclin D1 pathways [8,10,11,20]; and reduces levels
of thymidylate synthase and survivin which are key
molecules contributing to drug resistance in colon
cancer [17,19,21,22].
We hypothesize that as the colonic crypt cells
migrate up the crypt, they become increasingly
exposed to the colonic fluid in the lumen and
components in the colonic fluid trigger the induction
ofCaSR expression. BothCa2þ and vitaminDare good
candidates because both Ca2þ and vitamin D have
been shown to stimulate CaSR expression in the
parental CBS and HCT116 human colon carcinoma
cells [8,9,17,19]. A variety of other cationic minerals
in the colonic fluid may also serve as good candidates
in the induction of CaSR. Of interest is Aquamin—
that is, the calcium-rich, multi-mineral containing
remains of the red marine algae, Lithothamnion
calcareum. Aquamin has been shown to induce
differentiation in colon carcinoma cells [23] and
possess chemopreventive properties against colon
polyp formation in mice fed a high fat diet [23,24].
Both in vitro and in vivo, Aquaminwasmore effective
than Ca2þ alone at comparable levels.
In this report,wefirstcomparedthepotencyofCa2þ,
vitaminD, andAquamin in inhibiting cell growth and
inducing CaSR expression in the heterogeneous
human colon carcinoma CBS and HCT116 cell lines
maintained inconventional culturemedium.Wethen
compared the potency of the same agonists in growth
inhibition and CaSR induction in the CaSR null cells
(isolated from these cell lines and their null status
maintained in embryonic stem cell hESC medium)
that is, todetermine if theseagonists canovercomethe
constraint on CaSR expression exerted by the hESC
medium. Aquamin was found to be more robust than
either of the other agonists in growth inhibition and
CaSR induction. This was seen with both the parental
lines and the CaSR null cells derived from the two
lines. Demethylation of CpG islands in the CaSR gene
promoter was associated with CaSR inductionwith all
three agonists. Aquamin was most robust in the
induction of demethylation by comparison. Surpris-
ingly, demethylation of CpG islands per se was not
sufficient in CaSR induction and gene transcription.
Suppression of the molecular features associated with
the malignant CaSR null phenotype was a conse-
quence, and again, Aquamin was more potent than
Ca2þ alone or vitamin D. These results provide a
rationale for theuseof amulti-mineral approach in the
chemoprevention of colon cancer. Induction of CaSR
expression may be a measure of the effectiveness of a
chemopreventive agent.
MATERIALS AND METHODS
Cell Culture
Human colon carcinoma CBS and HCT116 cells
weremaintained in supplementalminimum essential
medium (SMEM). SMEM is essentially Ca2þ-free,
Minimum Essential Medium Eagle Joklik Modifica-
tion with L-glutamine (Sigma, St. Louis, MO) supple-
mented with sodium bicarbonate, peptone, vitamins,
amino acids, and 5% fetal bovine serum. Because
serum contains Ca2þ, the complete SMEM medium
supplemented with serum contains a low amount of
Ca2þ (0.175–0.2mM) [17,25]. These cell lines were
originally developed from primary human colon
tumors by Dr. Michael G. Brattain [26]. CaSR null
cells were isolated from the heterogeneous parental
CBS and HCT116 cells by magnetic cell sorting and
maintained in serum free, bovine serum albumin
containing hESC culture supplemented with 10ng/
mL Nodal and 10ng/mL Noggin as previously
described [14]. Aquamin is a multi-mineral-
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containingnatural product obtained from the skeletal
remains of Lithothamnion sp. of red marine algae [23]
and consists entirely of the inorganic minerals
accumulated from seawater by the organism (Marigot
Ltd, Cork, IR). The product contains approximately
12% calcium and 1% magnesium, but also has
detectable levels of 72 other trace minerals. The
concentration of Aquamin used in this study was
based on its calcium content.
Cell Proliferation Assay
Proliferation assays were performed as described
previously in six-well culture plates [19]. Parental and
CaSR null cells were seeded into their corresponding
culture media with or without Ca2þ, vitamin D or
Aquamin, dissolved in culture medium, in the
concentrations as indicated in the figures. After 48h
of culture, cellular proliferation was determined by
counting the number of viable cells using an
automatic Vi-CellTM XR Cell Viability Analyzer (Beck-
man Coulter, Fullerton, CA). Results shown represent
themean and standard error of triplicate experiments.
Real-Time RT-PCR
This procedure was performed as described previ-
ously [14]. Total RNA was extracted from 2106
pelleted parental or their corresponding CaSR null
cells by Tri reagent (Sigma). cDNA was synthesized
from 4mg of total RNA using a cDNA synthesis
kit according to the manufacturer’s instructions
(Fermentas life sciences, Glen Burnie, MD). Real
time RT-PCR was performed using the SYBR green
PCR amplification kit (Promega, Madison, WI) in a
real time PCR machine with specific primers for the
target genes. b-actin was used as internal controls for
equal loading of RNA in all real time RT-PCR experi-
ments. A comparative threshold cycle (Ct) was used to
determine the level of gene expression relative to
control and fold expression was calculated using the d
d cycle threshold (Ct) method [14]. Results shown
represent the mean and standard error of triplicate
independent experiments.
Western Analysis
Quantitative immunoblottings were performed as
previously described using primary anti-CaSR and
fluorescent labeled secondary antibodies [14,17]. A LI-
COR ODYSSEY (LI-COR Biosciences, Lincoln, NE)
instrument was used to detect and analyze the
binding of antibodies to protein of interest. Densito-
metric fold increase or decrease in protein expression
was calculated by comparison to control laneswith an
assigned value of one.
Luciferase Reporter Assays
Luciferase reporter assays were performed as de-
scribed previously [9,19]. Briefly, cells were seeded in
24-well culture plate and transfected with 1mg of
CaSR promoter 1 (P1) or promoter 2 (P2) luciferase
reporter construct and 0.1mg of Renilla luciferase
reporter construct using LipofectamineTM 2000 (In-
vitrogen Life Technologies) transfection reagent.
Ca2þ (1.4mM) or vitamin D (1mM) or Aquamin
(1.4mM) was added 24h after transfections. Lucifer-
ase activities were measured at 48h after Ca2þ or
vitamin D or Aquamin treatment. Transfection
efficiency were determined and normalized by Renilla
luciferase activities. Data shown represent the mean
and standard error of the mean of triplicate
experiments.
Bisulfite Treatment and Methylation Specific PCR
Genomic DNA isolation and methylation specific
PCR (MSP) was performed according to previously
described procedures [27]. MethPrime computational
softwarewasused topredict theCpGmethylation sites
in theCaSRpromoter [28]. Thirty-fourmajorCpG sites
were identified in the 694-bp fragment of the CaSR
promoter including the transcriptional start site
[21,28]. Genomic DNA was treated with sodium
bisulfite using a CpGenomeTM Turbo bisulfite modifi-
cation kit (EMDMillipore, Billerica, MA) according to
instructions provided by the manufacturer. In the
sodium bisulfite reaction, all unmethylated cytosines
were converted to uracils, while 5-methylcytosines are
resistant to this modification and remain unaltered.
MSP analysis was performed using primers targeting
the CaSR promoter region. Following bisulfite treat-
ment, two sets of MSP primers were used which were
designed specifically to amplify either a bisulfite-
sensitive (unmethylated) strand or a bisulfite-resistant
(methylated) strand. The forward and reverse primer
sequences for the unmethylated strand were (GAGTT-
TATTTTTGTGGAGATTTATGG) and (CCAACATA-
TACCCCTCATTCAAC), respectively. The forward
and reverse primer sequences for the methylated
strand were (GAGTTTATTTTCGTGGAGATTTACG)
and (GACGTATACCCCTCGTTCGA), respectively. As
an additional control, cells were treated with 1uM
5-aza-2’-deoxycytidine (5-aza-dc; Sigma Chemical, Co.,
St. Louis, MO) for 48h to induce DNA demethylation.
DNA from 5-aza-dc-treated cells was also analyzed
by MSP. PCR amplified products were analyzed by
agarose gel (2%) electrophoresis.
Statistical Analyses
Statistical analyses were performed using GraphPad
Prism software. Results were expressed as mean SE.
Statistical significance was calculated by using
Student’s unpaired t-test. P0.05 indicates a signifi-
cant difference by comparison with controls.
RESULTS
Inhibition of Cellular Proliferation and Induction of CaSR
Expression in Parental CBS and HCT116 Cells
Ca2þ, vitamin D, and Aquamin each inhibited
cellular proliferation in a dose dependent manner
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(Fig. 1 A and B). Side-by-side comparison of the anti-
proliferative effect of Ca2þ and Aquamin (from
physiologic 1.4mM to supra-physiologic 7.0mM)
demonstrated that Aquamin was more potent than
Ca2þ in inhibiting cell proliferation. The major
ingredient of Aquamin (in addition to containing
many other minerals) is Ca2þ. Therefore, an amount
of Aquamin that is equivalent to 1.4mM Ca2þ is of
physiologic relevance. Vitamin D (from physiologic
0.01mM to supra-physiologic 1.0mM) also inhibited
cell proliferationwhile 1mMconcentrationwas found
to be most potent.
Both Ca2þ and Aquamin induced a high level of
CaSR mRNA expression while vitamin D was relative-
ly less effective by comparison (Fig. 1C and D). At
high concentrations of either Ca2þ or Aquamin no
Figure 1. Inhibition of cell proliferation and induction of CaSR
expression in parental CBS and HCT116 carcinoma cell lines. A and B,
cell proliferation. Proliferation assay was performed as described in
Methods in conventional SMEM culture medium. The effect of Ca2þ,
vitamin D or Aquamin treatment on cell proliferation was compared to
that of untreated control cells. Results are expressed as number of viable
cells at the end of the culture period. Triplicate determinations were
performed in each experiment and the values shown represent the
mean and standard error of three independent experiments. C and D,
Real time RT-PCR analysis of the expression level of mRNA encoding
CaSR relative to that of untreated control cells. Results represent the
mean and standard error of the mean of triplicate determinations. b-
actin was used as loading control. A–D, asterisk () indicates the results
are of statistical significance. P< 0.05 significant; P< 0.01 very
significant; P< 0.001 extremely significant. E and F, Western blot
analysis of CaSR expression. Cells were treated for 48 h with
Ca2þ(1.4mM), vitamin D (1.0mM) or Aquamin (1.4mM Ca2þ) for
48 h. Protein expression was normalized and compared to untreated
controls with an assigned value of 1.0. b-actin was used as loading
control.
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induction of CaSR mRNA was seen, but this may
reflect toxicity. At equal molar concentrations (below
the 7.0mM level), Aquamin was more potent in CaSR
mRNA induction than Ca2þ. Vitamin D at 1mM
concentration also induced CaSR mRNA while lower
concentrationswere not effective. Next, we compared
the effectiveness of these agents in inducing CaSR
protein expression—that is, by Ca2þ at 1.4mM,
vitamin D at 1.0mM and Aquamin containing
1.4mM Ca2þ. Aquamin induced the highest level of
CaSR protein expression by comparison to Ca2þ or
vitamin D (Fig. 1E and F).
Inhibition of Cellular Proliferation and Induction of CaSR
Expression in CaSR Null Cells Isolated From the Parental
CBS and HCT116 Cells
Next, we compared the efficacy of Ca2þ (1.4mM,
physiologic concentration), vitamin D (1.0mM), and
Aquamin (1.4mM Ca2þ, physiologic concentration)
in inhibiting cell proliferation and CaSR induction in
the highlymalignant CaSR null cells cultured in hESC
culture medium. We wanted to determine if these
agents could overcome the constraint exerted by
hESCmedium inmaintaining the null phenotype. All
three agents could inhibit cell growth (Fig. 2A and B)
and induceCaSR expression at themRNA (Fig. 2C and
D) and protein levels (Fig. 2E and F). Aquamin was
found to be much more effective in this regard than
either Ca2þ alone or vitamin D, while vitamin D at
1.0mM concentration was slightly more effective by
comparison to 1.4mM Ca2þ.
Demethylation of CaSR Promoter CpG Sites
MethPrimer computational software had predicted
the CpG methylation sites in the CaSR promoter and
thirty-four major CpG sites have been identified in
the 694-bp fragment of the CaSR promoter including
the transcriptional start site [21]. We have previously
reported that methylation of CpG islands could be
responsible for maintaining the null status of CaSR
null cells cultured in human embryonic stem cell
culture medium as these sites were demethylated and
CaSR expressionwas inducedwhen the null cells were
placed in conventional SMEM culture medium con-
taining fetal bovine serum [21]. Here we determined
whether Ca2þ, vitamin D, or Aquamin could also
induce demethylation of the CaSR promoter in CaSR
null cells cultured in hESC culture medium. MSP
analysis of CaSR null cells revealed the presence of
methylated PCR product with or without sodium
bisulfite treatment (Fig. 3 A and B) while 5-aza-dc
treatment induced demethylation of these CpG
islands along with the detection of unmethylated
PCR product (Fig. 3 A and B). Figure 3C andD, lanes 3,
4, and 5 shows the increase in unmethylated PCR
products upon treatment with Ca2þ, vitamin D, or
Aquamin. Figure 3C and D, lanes 1 shows methylated
PCR product in the CaSR null cells and lanes 2 shows
unmethylated PCR product in the null cells treated
with 5-aza-dc. In conjunctionwith promoter demeth-
ylation, CaSR promoter reporter assays revealed an
increase in the activation of both the P1 (Fig. 3 E and
F) and P2 (Fig. 3 G and H) promoters of the CaSR gene
when the null cells were treatedwithCa2þ, vitaminD,
or Aquamin. Overall, Aquamin was relatively more
robust in the demethylation of CpG islands in the
CaSR promoter and, concomitantly, more potent in
the transcriptional up-regulation of both the P1 and
P2 promoter of theCaSR gene. The resultswere similar
with both cell lines. However, we found that 5AZA-dc
treatment per se did not induce CaSR transcription.
Thus, demethylation of CpG islands alone was not
sufficient to induce CaSR transcription.
Changes in the Molecular Phenotype of CaSR Null Cells by
Ca2þ, Vitamin D, or Aquamin
Isolated CaSR null cellsmaintained in hESC culture
medium possess a myriad of molecular features that
are associated with the malignant phenotype [14].
CaSR null cells, however, regain CaSR expression
when these cells were seeded into conventional
culture medium containing FBS with a concurrent
suppression of the malignancy associated molecular
features [21]. More importantly, changes in the
molecular features of the null cells is directly linked
to the induction of CaSR expression because blocking
CaSR inductionby shRNAnegated these changes [21].
. Here, we determined if induction of CaSR expression
in the CaSR null cells (cultured in hESC culture
medium) by Ca2þ, vitamin D, or Aquamin would be
sufficient to change the molecular features of the
CaSR null cells. Parental cell lines were used as
controls which represent the gene expression profile
of these cell lines. The majority of the cells in the
parental lines express CaSR with only a small
percentage that are CaSR null [14]. RT-PCR was
used in this analysis at the RNA level. Indeed,
treatment of the null cells by Ca2þ, vitamin D, or
Aquamin down-regulated the expression of malig-
nancy associated EMT molecules (N-cadherin, b-
catenin, fibronectin and vimentin); EMT associated
transcription factors (Snail-1, Snail-2, and Twist);
oncogenic miRNAs (miR-21, miR-135a and miR-
135b) and drug resistant protein survivin and TS
(Fig. 4A and C). Aquamin was found to be most
potent in this regard. In addition to the down-
regulated expression of the malignancy associated
molecules described above, Ca2þ, vitamin D, or
Aquamin up-regulated expression of tumor suppres-
sivemolecules E-cadherin,miR-145 andTGFb-R1 and
TGFb-R2 (Fig. 4 B and D). Again, Aquamin was found
to be most potent in this regard.
DISCUSSION
The expression of CaSR in both the CBS and
HCT116 cell lines is heterogeneous—that is, with
cells expressing different levels of CaSR [14,17]. We
previously isolated CaSR null cells from both parental
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cell lines and demonstrated that the null status of
these cells was maintained in hESC culture medium.
CaSR null cells were found to possess a myriad of
cellular and molecular features that are linked to a
highly malignant and drug resistant phenotype [14].
Of interest, CaSR null cells were able to differentiate
and acquire CaSR expression with a concurrent
reversal of the CaSR null molecular phenotype
when these cells were seeded into conventional
culture medium containing fetal bovine serum [21].
The change in phenotype requires the induction of
CaSR expression [21] as phenotypic changes did not
occur when CaSR induction was prevented. The
coexistence of CaSR null cells with cells that express
various levels of CaSR could indicate a stem-like
nature of the CaSR null phenotype. We have
hypothesized that CaSR null cells possess stem-like
property, resembling that of the colonic crypt stem
cells in vivo which are CaSR null [14]. The expression
of CaSR in the parental CBS and HCT116 cells is
extremely heterogeneous with cells expressing a very
low level of CASR to cells that express a very high level
of CaSR [14]. We hypothesize that a dynamic process
of cell death and revival occurs in a culture and that
CaSR null cells divide asymmetrically to replenish
themselves and also differentiate into CaSR positive
cells which will eventually apoptose and die. The
expression profile of stem cell markers and survival
Figure 2. Inhibition of cell proliferation and induction of CaSR
expression in CaSR null cells isolated from the CBS and HCT116 cell
lines. A and B, cell proliferation. This assay was performed with the
CaSR null cells cultured in hESC culture medium. Cells were treated
with Ca2þ (1.4mM), vitamin D (1.0mM) or Aquamin (1.4mM Ca2þ)
for 48 h. Cultures without treatment served as controls. The results
presented here, number of viable cells; represent the mean and
standard error of the mean of triplicate experiments. C and D,
induction of CaSR mRNA in CaSR null cells cultured in hESC culture
medium. The expression level of mRNA encoding CaSR relative to that
of untreated control cells was determined by real time RT-PCR. CaSR
null cells were treated with Ca2þ (1.4mM), vitamin D (1.0mM), or
Aquamin (1.4mM Ca2þ) for 48 h. b-actin was used as loading control.
Triplicate assays were performed in each experiment and the values
shown represent the mean and standard error of three independent
experiments. A–D, asterisk () indicates the results are of statistical
significance. P< 0.05 significant; P< 0.01 very significant; P
< 0.001 extremely significant. E and F, Western blot analysis of CaSR
protein expression from CaSR null cells treated with Ca2þ, vitamin D
or Aquamin as described above. b-actin was used as loading controls.
As shown, untreated CaSR null cells do not express CaSR [14]. The
level of protein expression in cells treated with vitamin D or Aquamin
was compared to that of the Ca2þ treated cells with an assigned value
of 1.0
548 SINGH ET AL.
Molecular Carcinogenesis
markers in CaSR null cells [14] lend support to this
hypothesis.
Previous studies have shown that Ca2þ or vitaminD
can inhibit cell growth and induce CaSR expression in
the parental CBS and HCT116 cells [9,19]. In the
present study, we first determined and compared the
effectiveness of three CaSR agonists (i.e., Ca2þ alone,
vitamin D, and Aquamin) in growth inhibition and
CaSR induction in the parental cells. We then extend
the analysis to the isolated CaSR null cells cultured in
Figure 3. Demethylation of CaSR promoter and stimulation of CaSR
promoter transcriptional reporter activities. Bisulfite and 5-aza-dc
untreated or treated DNA was PCR-amplified using two different
primers,one thatamplifiesunmethylatedDNA(U), andanother amplifies
methylatedDNA (M).AandB,MSPanalysis ofCaSRpromoter in null cells
anddemethylationof thepromoterby 5-aza-dc.CandD,MSPanalysisof
CaSR promoter in null cells by treatmentwith 5-aza-dc or treatmentwith
Ca2þ (1.4mM) or vitamin D (1mM) or Aquamin (Ca2þ 1.4mM Ca2þ).
Cells were treated for 48h prior to MSP analysis. E and F, relative
transcriptional activities of the P1 andG and H, P2 CaSR promoter in the
CaSR null cells treated with Ca2þ (1.4mM) or vitamin D (1mM) or
Aquamin (Ca2þ 1.4mM Ca2þ) for 48h. Triplicate determinations were
performed in each experiments and the results shown represent the
mean and standard error of three independent experiments. Asterisk ()
indicates the results are of statistical significance. P< 0.05 significant;
P< 0.01 very significant; P< 0.001 extremely significant.
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hESC culture medium. With regard to the null cells,
we also determined the effectiveness of the three
agonists in altering the molecular phenotype of these
cells. Overall, vitamin D was effective in inhibiting
cell growth and inducing CaSR in both the parental
and CaSR null cells, but required supra physiologic
concentration (1.0mM) for activity. A physiologic
concentration of Ca2þ (1.4mM) provided either alone
or as part of a multi-mineral-rich natural product was
also effective in this regard. Compared to Ca2 alone,
Ca2þ in conjunction with the other trace elements
present in Aquamin had greater activity. Along with
the induction of CaSR, Aquamin was also found to be
more potent than Ca2þ or 1.0mM vitamin D in
stimulating CaSR promoter reporter activities, deme-
thylating the CaSR promoter and altering the
Figure 4. Real time RT-PCR analysis of the changes in the molecular
profile of CaSR null cells upon CaSR induction. The gene expression
profiles of treated CaSR null cells were compared to that of their
correspondingcontrolparentalCBSandHCT116cells.AandC, relative%
reduction in mRNA expression level encoding EMT associated molecules
and transcription factors, oncogenicmiRNAandchemoresistant proteins.
B and D, relative % increase in mRNA expression encoding tumor
suppressive mRNAs andmiRNA. b-actin was used as loading controls for
real time RT-PCR. Values were normalized and compared to that of
untreated controls with a base line value of 1.0. Triplicate assays were
performed in each experiment and the values shown represent themean
and standarderrorof three independentexperiments.With the exception
of the b-catenin expression profile in A and the b-catenin expression
profile in C treatedwith vitamin D, the results obtainedwere of statistical
significance (unpaired Student's t-test) with P values ranging from 0.05
(significance) to 0.001 (extremely significant).
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molecular phenotype of the CaSR null cells main-
tained in hESC culture medium. Changes in the
molecular phenotype include the down-regulated
expression of EMT associated proteins and transcrip-
tion factors and the up-regulated expression of the
tumor suppressors E-cadherin, miR-145 and TGFb-R1
and TGFb-R2. Interestingly, treatment of CaSR null
cells with 5AZA-dc alone also results in the demethyl-
ation of CaSR promoter but without gene transcrip-
tion. Thus, demethylation of these CpG islands alone
is not sufficient to stimulate CaSR expression.
In the colonic crypts, how the expression of CaSR is
regulated as the CaSR null crypt stem cells migrate
and differentiate upwards in the direction of the
lumen is unknown. The present studies, using
isolated CaSR null cells, support our hypothesis that
exposure to nutrients in the colonic fluids such as
Ca2þ, vitamin D, and various other minerals could be
the triggers. Presumably, the induction ofCaSRwould
propel the crypt stemcells into thenormal pathway of
differentiation. In fact, in the colonic crypt, the fully
differentiated cells at the apex of the crypt (where the
Ca2þ concentration is highest) express the highest
level of CaSR [8,12]. The expression of TGFb in the
colonic crypt has also been reported to be linked to
differentiation — that is, there is a high level of TGFb
expression in the upper portion of a crypt by
comparison to the lower portion of the crypt [29].
TGFb is a potent growth inhibitor and differentiation
promoter in colonic epithelial cells and mediates its
action through TGFb-R1 and TGFb-R2 [30–32].
Interestingly, we recently found that in human colon
carcinoma cells, responsiveness to TGFb requires
CaSR [25]. Thus, it is not surprising that TGFb
receptors were up-regulated along with the induction
of CaSR.
The chemopreventive activity of Ca2þ in the colon
iswell established, based onboth epidemiological and
interventional studies [33–39]. While Ca2þ (alone or
in conjunction with vitamin D) has acknowledged
capacity to reduce polyp formation in the colon, its
efficacy can be described as modest. It has been
suggested that under conditions of optimal usage, a
decrease in polyp formation of approximately 20%
might be achieved [40]. Further, while Ca2þ supple-
ments are generally considered safe, a meta-analysis
of the Ca2þ supplementation literature came to the
conclusion that long-term use of such supplements
was associatedwith an increased risk of cardiovascular
events [41]. In recent studies we demonstrated that
Aquamin (i.e., the mineralized remains of the red
marine algae, Lithothamnion sp.) reduced polyp
formation in genetically normal mice on a high fat
diet [24,42]. This natural product, which contains
Ca2þ but also contains significant amounts of Mg2þ
and detectable levels of 72 additional trace minerals,
was more effective than Ca2þ alone at comparable
Ca2þ levels [42]. In other studies, Aquaminwas shown
to be more effective than Ca2þ alone at suppressing
proliferation and inducing differentiation in human
colon cancer cells in vitro [43]. The present observa-
tion — that is, demonstrating increased effectiveness
of Aquamin in up-regulating CaSR expression relative
to Ca2þ alone — provides a plausible explanation for
its enhanced efficacy. The molecular basis for the
enhanced efficacy of Aquamin (relative toCa2þ alone)
is not fully understood. However, previous studies
have demonstrated that several of the trace elements
present in Aquamin are capable of binding to CaSR in
place of Ca2þ. Some of these, including members of
the lanthanoid family of “rare earth” elements have a
higher affinity for CaSR than Ca2þ itself [44,45].
Although the present studies demonstrate that
Aquamin ismore effective thanCa2þ alone or vitamin
D at up-regulating CaSR expression (both in the
parental lines and in the CaSR null cells), qualitative-
ly, the three agonists are similar.
All three agonists demethylated theCaSRpromoter,
stimulated CaSR promoter reporter activities, and
altered themolecular phenotype of theCaSRnull cells
maintained in hESC culture medium. Changes in the
molecular phenotype included the down-regulated
expression of several EMT-associated proteins and
transcription factors and the up-regulated expression
of the tumor suppressors including E-cadherin, miR-
145 and TGFb-R1 and TGFb-R2. Whether these
agonists can induce similar molecular changes in
CaSR null cancer cells or in the normal basal crypt
stem cells in vivo, however, is unknown and will
require further investigation. Thus, the data support
the notion that modulating CaSR expression has
“global” effects on growth and differentiation path-
ways in colonic epithelial cells. In colon carcinoma
cells, the biologic action of vitamin D closely
resembles that of CaSR [9,46]. The human CaSR
gene has two promoters and each promoter has a
transcriptional start site containing a vitamin D
response elements [28,47]. Ca2þ or vitamin D can
stimulate CaSR promoter activity and CaSR protein
expression [9]. Much of the action of vitamin D in
human colon carcinoma cells is dependent on CaSR
expression and function because blocking the expres-
sion of CaSR by shRNA abrogates the biologic effects
of vitamin D [19]. Thus, a strong molecular linkage
exist between vitamin D and CaSR.
In summary, our data show that either Ca2þ or
vitamin D could directly induce CaSR expression in
colonic epithelial cells, leading to differentiation and
growth reduction. However, Aquamin was more
effective than either Ca2þ alone or vitamin D as a
CaSR inducer. To the extent that these in vitro
observations reflect responses occurring in the intact
colon, these data help to understand how CaSR
expression is regulated in the colon, and provide a
rationale for the use of a multi-mineral approach in
place of Ca2þ alone as a colon polyp/cancer chemo-
preventive. The efficacy of Aquamin needs to be
confirmed in controlled clinical studies.
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